MAPLIGHT THERAPEUTICS INC (MPLT) — insider trading
Health Care · NASDAQ
MAPLIGHT THERAPEUTICS INC (MPLT) has 56 reported SEC Form 4 insider transactions in our data, including 44 open-market sales among the most recent 56 (latest 2026-07-17).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | Kreitzer Anatol | Officer (Chief Discovery Officer) | Open-market sale | 200 | $38.39 | $7.7K | Form 4 |
| 2026-07-17 | Kreitzer Anatol | Officer (Chief Discovery Officer) | Open-market sale | 14,140 | $37.70 | $533.1K | Form 4 |
| 2026-07-17 | Kreitzer Anatol | Officer (Chief Discovery Officer) | Open-market sale | 2,833 | $37.05 | $105.0K | Form 4 |
| 2026-07-17 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | Open-market sale | 900 | $38.17 | $34.4K | Form 4 |
| 2026-07-17 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | Open-market sale | 16,969 | $37.61 | $638.2K | Form 4 |
| 2026-07-17 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | Open-market sale | 600 | $36.51 | $21.9K | Form 4 |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 3,656 | $37.90 | $138.6K | Form 4 |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | Open-market sale | 1,130 | $37.90 | $42.8K | Form 4 |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | Open-market sale | 2,077 | $37.90 | $78.7K | Form 4 |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | Open-market sale | 16,779 | $37.90 | $635.9K | Form 4 |
| 2026-07-16 | Kreitzer Anatol | Officer (Chief Discovery Officer) | Open-market sale | 1,592 | $37.44 | $59.6K | Form 4 |
| 2026-07-16 | Kreitzer Anatol | Officer (Chief Discovery Officer) | Open-market sale | 7,464 | $36.66 | $273.6K | Form 4 |
| 2026-07-16 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | Open-market sale | 1,476 | $37.44 | $55.3K | Form 4 |
| 2026-07-16 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | Open-market sale | 6,979 | $36.66 | $255.9K | Form 4 |
| 2026-07-16 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 19 | $37.96 | $721 | Form 4 |
| 2026-07-16 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 5,865 | $37.26 | $218.5K | Form 4 |
| 2026-07-16 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 9,163 | $36.46 | $334.1K | Form 4 |
| 2026-07-16 | Hanson Kristopher | Officer (General Counsel) | Open-market sale | 11 | $37.96 | $418 | Form 4 |
| 2026-07-16 | Hanson Kristopher | Officer (General Counsel) | Open-market sale | 3,331 | $37.26 | $124.1K | Form 4 |
| 2026-07-16 | Hanson Kristopher | Officer (General Counsel) | Open-market sale | 4,776 | $36.45 | $174.1K | Form 4 |
| 2026-07-16 | Lillie James Woodruff | Officer (Chief Scientific Officer) | Open-market sale | 12 | $37.96 | $456 | Form 4 |
| 2026-07-16 | Lillie James Woodruff | Officer (Chief Scientific Officer) | Open-market sale | 3,526 | $37.26 | $131.4K | Form 4 |
| 2026-07-16 | Lillie James Woodruff | Officer (Chief Scientific Officer) | Open-market sale | 5,009 | $36.45 | $182.6K | Form 4 |
| 2026-07-16 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | Open-market sale | 92 | $37.96 | $3.5K | Form 4 |
| 2026-07-16 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | Open-market sale | 28,091 | $37.26 | $1.05M | Form 4 |
| 2026-07-16 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | Open-market sale | 40,899 | $36.46 | $1.49M | Form 4 |
| 2026-07-15 | Kreitzer Anatol | Officer (Chief Discovery Officer) | Open-market sale | 4,510 | $36.94 | $166.6K | Form 4 |
| 2026-07-15 | Kreitzer Anatol | Officer (Chief Discovery Officer) | Open-market sale | 5,545 | $36.13 | $200.3K | Form 4 |
| 2026-07-15 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | Open-market sale | 4,699 | $36.94 | $173.6K | Form 4 |
| 2026-07-15 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | Open-market sale | 5,356 | $36.13 | $193.5K | Form 4 |
| 2026-07-15 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 18 | $37.54 | $676 | Form 4 |
| 2026-07-15 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 8,972 | $36.99 | $331.9K | Form 4 |
| 2026-07-15 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 4,465 | $36.00 | $160.7K | Form 4 |
| 2026-07-15 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 7,845 | $37.04 | $290.6K | Form 4 |
| 2026-07-15 | Foff Erin Pennock | Officer (Chief Medical Officer) | Open-market sale | 7,155 | $36.16 | $258.7K | Form 4 |
| 2026-07-15 | Hanson Kristopher | Officer (General Counsel) | Open-market sale | 10 | $37.54 | $375 | Form 4 |
| 2026-07-15 | Hanson Kristopher | Officer (General Counsel) | Open-market sale | 5,103 | $36.99 | $188.8K | Form 4 |
| 2026-07-15 | Hanson Kristopher | Officer (General Counsel) | Open-market sale | 2,147 | $36.00 | $77.3K | Form 4 |
| 2026-07-15 | Lillie James Woodruff | Officer (Chief Scientific Officer) | Open-market sale | 12 | $37.54 | $450 | Form 4 |
| 2026-07-15 | Lillie James Woodruff | Officer (Chief Scientific Officer) | Open-market sale | 5,393 | $36.99 | $199.5K | Form 4 |
| 2026-07-15 | Lillie James Woodruff | Officer (Chief Scientific Officer) | Open-market sale | 2,238 | $36.00 | $80.6K | Form 4 |
| 2026-07-15 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | Open-market sale | 90 | $37.54 | $3.4K | Form 4 |
| 2026-07-15 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | Open-market sale | 42,738 | $36.99 | $1.58M | Form 4 |
| 2026-07-15 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | Open-market sale | 18,950 | $36.00 | $682.2K | Form 4 |
| 2026-06-23 | Walker Maria C | Director | Grant / award / vesting (derivative) | 14,902 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Walker Maria C | Director | Grant / award / vesting | 3,932 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Pavlov George | Director | Grant / award / vesting (derivative) | 14,902 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Pavlov George | Director | Grant / award / vesting | 3,932 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Luneborg Nanna Liebach | Director | Grant / award / vesting (derivative) | 14,902 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Luneborg Nanna Liebach | Director | Grant / award / vesting | 3,932 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Garnett Timothy John | Director | Grant / award / vesting (derivative) | 14,902 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Garnett Timothy John | Director | Grant / award / vesting | 3,932 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Babler Martin | Director | Grant / award / vesting (derivative) | 29,804 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Babler Martin | Director | Grant / award / vesting | 7,864 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Cox Troy | Director | Grant / award / vesting (derivative) | 29,804 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Cox Troy | Director | Grant / award / vesting | 7,864 | $0.00 | $0 | Form 4 |
Ask the chat about MPLT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: MAPLIGHT THERAPEUTICS INC (MPLT).
Last updated 2026-07-17 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.